{"id":1279,"date":"2024-07-17T19:49:22","date_gmt":"2024-07-17T19:49:22","guid":{"rendered":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/?page_id=1279"},"modified":"2026-08-10T15:48:54","modified_gmt":"2026-08-10T15:48:54","slug":"company","status":"publish","type":"page","link":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/","title":{"rendered":"Company"},"content":{"rendered":"

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\n\t\t\t\t\t\t

Our Company<\/h1>\n\t\t\t\t\t\t\n\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\n\t\t\t\t<\/div>\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/section>\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\"\"<\/span>\n\t\t\t<\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Vision<\/h2><\/div>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

The vision of GT Metabolic\u2122 is to complement and expand the MBS market. We offer a portfolio of MIS products and techniques that benefit both patients and surgeons. Our solutions are incisionless, inexpensive, leave no foreign bodies, are reversible, and facilitate staging of procedures in the outpatient setting<\/span>. Focused for launch in the metabolic\/bariatric surgery space, the technology has the potential to disrupt other fields, including gastrointestinal, thoracic, biliary, colorectal, urological, and vascular surgery in the near future.<\/span><\/p>\n

GT Metabolic is already a clinically involved company, partnering with leading bariatric and metabolic surgeons all over the world<\/span>. Our initial preclinical and clinical trials are moving forward well. We look forward to advancing through the regulatory process to come into active commercial status globally.<\/span><\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>

\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Who We Are<\/h2><\/div>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
GT Metabolic is leading the world with its development of magnetic compression anastomosis technologies for next-stage minimally invasive procedures. An elegant approach that uses magnets to help achieve anastomosis, the incisionless, sutureless, staple-free technique leaves behind no foreign material to impede the natural tissue healing process. Our team has engineered a magnetic compression solution called delayed anastomosis technology (DAT) that surgeons can use to create consistent anastomosis while helping minimize potential complications, such as leaks and bleeds, in challenging applications. Our solution democratizes the surgical approach to anastomosis. It can be used in procedure staging and is reversible. GT Metabolic is disrupting the market by introducing magnetic compression anastomosis technologies to bariatric, metabolic, and digestive health providers globally.<\/span><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Management Team<\/h1><\/div>\n\t\t\t<\/div>
<\/div><\/div>\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Thierry Thaure<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

CEO & Co-founder<\/h3><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Thierry Thaure has over 35 years of experience in medical device technology as an entrepreneur and Chief Executive Officer (CEO). He has demonstrated repeated success in building businesses with disruptive technologies and driving their market expansion.<\/p>\n

Mr. Thaure was co-founder and CEO of Cephea Valve Technologies, a company that developed a percutaneous mitral valve replacement technology, which was purchased by Abbott in 2019 for $200M. Previously, he served as CEO of EndoGastric Solutions (formerly EsophyX); SVP of Accuray, a leader in radiosurgery, which he helped take public; and founding Vice President of Sales & Marketing at Intuitive Surgical.<\/p>\n

Mr. Thaure also held key management roles at Guidant, Origin Medsystems, and Edwards Life Science. Mr. Thaure holds a B.S. in chemistry and biomedical engineering from Duke University and an M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Michel Gagner, MD<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

CMO & Co-founder<\/h3><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Michel Gagner, M.D., obtained a Diploma in Sciences at the Seminaire de Sherbrooke in Sherbrooke in 1978 and his M.D. from the Faculte de Medecine de l\u2019Universite de Sherbrooke in Canada in 1982. He finished his surgical training at McGill University in Montreal from 1982-1988. During his residency, he completed two years of a Ph.D. program on human lipolysis in sepsis at the Royal Victoria Hospital, McGill University from 1984-1986. Dr. Gagner also completed fellowships in hepatic surgery at Hopital Villejuif in Paris, France, and pancreatico-biliary surgery at Lahey Clinic Medical Center in Burlington, Massachusetts, from 1989-1990.<\/p>\n

Upon completion of his fellowships, he was recruited to the Universite de Montreal School of Medicine, Hotel-Dieu de Montreal, where he was Assistant Professor of Surgery (1990-1995). He served several years at the Cleveland Clinic Foundation in Cleveland where he co-founded the Minimally Invasive Surgery Center (1995-1998). He was appointed the Franz Sichel Professor of Surgery and Director of the Minimally Invasive Surgery Center of Mount Sinai School of Medicine in New York from 1998-2003. Dr. Gagner joined Weill Medical College of Cornell University in New York as Professor of Surgery and Chief of the Section of Laparoscopic and Bariatric Surgery from2003-2007. Until recently, he served as Chair of the Department of Surgery at the Mount Sinai Medical Center in Miami and as Professor of Surgery at Florida International University. Dr. Gagner is currently Chief of Surgery of the Westmount Square Surgical Center and is a senior attending at the Hopital du Sacre Coeur in Montreal.<\/p>\n

Dr. Gagner is known for his contributions in the field of minimally invasive surgery, in particular the first description of laparoscopic adrenalectomy for Cushing syndrome and pheochromocytoma (1992), first description of laparoscopic pancreatectomy (distal and proximal) (1992-93), first description of endoscopic neck surgery with parathyroidectomy in 1995, first transgastric cholecystectomy in 1997 (NOTES), first description of laparoscopic duodenal switch for obesity in 1999, and laparoscopic sleeve gastrectomy in 2000. More recently, he was co-surgeon for the first world transatlantic robotic cholecystectomy, between New York City and Strasbourg, France, with the only surgical article published in\u00a0<\/span>Nature<\/em>\u00a0<\/span>in 2001.<\/p>\n

Dr. Gagner has published over 544 works, comprised of original articles, chapters, and books on minimally invasive surgery. He has been visiting professor and operated in over 60 institutions in 48 countries. He has held prominent positions in more than 35 societies and organizations and has served on the editorial boards of 12 surgical journals.<\/p>\n

Dr. Gagner also has received a number of honorary memberships and awards throughout his career. His most recent contributions focus on innovative upper digestive tract surgery such as bariatric and endoluminal gastric procedures.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Marcus Voss<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

VP, Sales<\/span><\/h3>\n

<\/span><\/p><\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Marcus Voss is a proven sales executive with 20+ years of experience building high-performing teams and driving growth in the medical device and life science industries. Most recently, he served as U.S. Plastic Surgery Leader at W.L. Gore & Associates, where he developed, launched, and scaled a national sales and clinical organization dedicated to advancing reconstructive surgery. In this role, he drove portfolio expansion, secured nationally recognized clinical trial sites, and built strategic partnerships with leading surgeons.<\/p>\n

Previously, as Regional Sales Leader in Gore\u2019s General Medical Products division, Marcus focused on developing the minimally invasive general and bariatric surgery markets. He transformed his region into one of the company\u2019s top performers. His leadership advanced future company leaders and strengthened physician engagement through global sales training, CRM adoption, and the design of education programs that accelerated growth.<\/p>\n

Earlier in his career, Marcus held roles with Covidien (Medtronic), LMA North America, and Novartis Pharmaceuticals, where he launched new technologies, grew capital equipment sales, and consistently ranked among the top national performers.<\/p>\n

Recognized for cultivating a culture of accountability, collaboration, and professional growth, Marcus is known for developing talent, aligning strategy with execution, and delivering sustained results in competitive markets.<\/p>\n

He holds a degree in Business Management from Hope College. He lives in Hudsonville, Michigan, with his family.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Lisa Griffin Vincent, PHD MA<\/span><\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Chief Regulatory, Quality, and Clinical Officer Chief of Staff<\/span><\/h3><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Lisa Griffin Vincent, Ph.D., has more than 30 years of experience in scientific, regulatory, and business leadership across the healthcare ecosystem within medical technology and combination products, payers, data analytics and population health, and management and diligence consulting. Her career began serving patients as a clinical and research nurse in neonatology, neurology, cardiovascular, and infectious diseases.<\/p>\n

Dr. Vincent has expertise leading and growing functional talent and organizations along the product lifecycle, including research, clinical, regulatory, health economics, reimbursement, medical affairs, and market access. In addition, she has guided business leadership including serving on executive teams, as chief operating officer for two global research companies, and as president of an outcomes research division. Her industry trajectory includes early-stage companies, such as Seismed Instruments, and PatientPoint, and large multinational organizations, such as UnitedHealth Group (UHG), Medtronic, BD, and GE Healthcare. Dr. Vincent has significant experience in the policy area and was appointed in January 2022 as an industry representative to the U.S. Department of Health and Human Services (DHHS) CMS Medicare Evidence Development and Coverage Advisory Committee (MEDCAC).<\/p>\n

Dr. Vincent holds a B.S. in nursing, M.A. in kinesiology, and Ph.D. in health services research and policy, all from the University of Minnesota. She was awarded full scholarships from the U.S. Agency for Health Care Policy and Research and DHHS for her doctoral training, and her dissertation focused on patient adherence to complex medical therapies to maximize health and economic efficiencies and reduce disease burden.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Mike Reiland<\/span><\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

VP, Quality & Operations<\/h3><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Mike Reiland has more than 25 years of experience in the medical device industry, with expertise spanning all aspects of quality and compliance throughout the product life cycle\u2014from early-stage development through commercial sales. He has worked across a broad range of medical device organizations, including Metavention, Conventus Orthopaedics, Torax Medical, St. Jude Medical, Intratherapeutics, and Urologix. His experience includes a strong understanding of manufacturing processes, manufacturing flow, and facility organization, allowing him to effectively integrate quality and compliance requirements into efficient, practical manufacturing operations. Mike holds a Bachelor of Science degree in Manufacturing Engineering, with a minor in Quality Engineering.<\/p>\n

<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>

\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Todd Krinke<\/span><\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

VP, Research & Development<\/h3><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Todd Krinke brings innovation and actualization to 18 years of medical device experience, with more than 20 issued patents and many pending applications. At Conventus Orthopaedics, Mr. Krinke developed the Conventus CAGE\u2122, a nitinol device with three indications to treat periarticular fractures: distal radius, proximal humerus, and proximal radius.\u00a0<\/p>\n

Mr. Krinke has also been Director of Research and Development for Endometabolic Solutions, where he developed an incisionless gastric bypass procedure, and Director of Product Engineering for Travanti Pharma, where he invented a new drug transfer system for a combination transdermal iontophoretic patch and led a 200-patient, 10-center Phase II clinical trial. At St. Jude Medical, Mr. Krinke developed the Gen II Symmetry nitinol anastomotic connector, percutaneous mitral valve repair, and carotid stent technologies. Mr. Krinke holds a B.S. in aerospace engineering and mechanics from the University of Minnesota.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Kate Taylor<\/span><\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

VP, Finance & Controller<\/span><\/h3><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t
\n
\n

Kate Taylor has 25 years as an experienced leader, manager, and director of finance, accounting, human resources, information technology, and business operations teams. More than half of this time has been spent in manufacturing, including medical devices within minimally invasive surgery and orthopedic implants and instrument spaces. \u00a0<\/p>\n

Ms. Taylor brings cross-functional leadership experience with a unique approach to bridging finance and accounting as a support function to company goals and objectives. She thrives on creating and sustaining advanced processes to strengthen company profits and competitive position, while ensuring regulatory compliance.<\/p>\n

Ms. Taylor has a B.S. in accounting from Cardinal Stritch University Madison, has a degree in executive education in management accounting from the University of St. Thomas, and is a member of the Institute of Management Accountants, Minneapolis Chapter.<\/p>\n<\/div>\n<\/div><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Scientific & Technical Advisors<\/h2><\/div>\n\t\t\t<\/div>
<\/div><\/div>\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Antonio J. Torres, MD, PhD<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Antonio Torres, M.D., Ph.D., is Professor of Surgery at Complutense University Medical School, Madrid, Spain. He leads the General Surgery Department at Hospital Clinico San Carlos. He was President of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) from2011-2012 and Chairman of IFSO\u00b4s Board of Trustees from 2015-2019.<\/p>\n

In addition, he runs the Multidiciplinary Unit for Obesity Treatment at the University Hospital Madrid, Monteprincipe.<\/p>\n

Dr. Torres has been involved in bariatric and metabolic surgery since 1985 having already performed more than 10.000 primary and revisional bariatric or metabolic procedures.<\/p>\n

He pioneered a new hypoabsortive procedure: SADIS procedure (Single Anastomosis Duodeno-Ileal anastomosis with Sleeve). Dr. Torres is also an Honorary Fellow of the American College of Surgeons (2022) (Hon F.A.C.S.).<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Helmuth T. Billy, MD<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Helmuth T. Billy, M.D., has been in private practice in Ventura California for over 20 years where he is the senior surgeon at Ventura Advanced Surgical Associates, specializing in laparoscopic bariatric and minimally invasive surgery (MIS). He has been a national leader in bariatric and revisional surgery, introducing cutting edge and innovative operations for the treatment of obesity in Southern California. He was one of the first surgeons in the state to incorporate the single anastomosis duodenal ileostomy (SADI procedure) into his practice. Dr. Billy has some of the most extensive experience utilizing the one anastomosis gastric bypass (OAGB) for the treatment of morbid obesity, and he was instrumental in the recent announcement by the American Society for Metabolic and Bariatric Surgery (ASMBS) endorsing OAGB as a recognized operation for the treatment of obesity.<\/p>\n

With over 20 years of experience as a bariatric surgeon, he was involved in establishing the first bariatric surgery programs at the Sutter Hospital system in Northern California. Since moving his practice to Ventura in 2002, he has been the Director of Bariatric Surgery at St. John\u2019s Regional Medical Center in Oxnard and Community Memorial Hospital in Ventura. Both hospitals are recognized by the America College of Surgeons (ACS) as accredited bariatric programs. Dr. Billy is a member of the core teaching faculty at Community Memorial Hospital, where he is active in graduate medical education of surgical residents and medical students. He has been the president of the Southern California Chapter of the ASMBS and is currently an at-large member of the executive council of the ASMBS.<\/p>\n

Dr. Billy obtained his undergraduate degree in molecular biology at the University of California, Berkeley. He subsequently received his medical degree at the University of California, Davis, School of Medicine. Since 2001, Dr. Billy has been active in the education of surgeons as a faculty member teaching the placement of the lap-band system. He has educated and proctored surgeons throughout the western U.S. in various techniques in laparoscopic bariatric surgery. He has also been involved in MIS fellowship training and has lectured and taught principles of bariatric surgery in Mexico, Taiwan, India, the UK, and throughout the Middle East. He held a teaching position at Hamad General Hospital in Doha, Qatar, spending over five years directly mentoring and teaching advanced MIS techniques in both bariatric surgery and complex revision operations. Dr. Billy has achieved an international reputation as an accomplished surgeon and educator in the fields of MIS and bariatric surgery.<\/p>\n

He has been a faculty member at numerous national educational events and surgeon training workshops. He has been a featured speaker at the annual meeting of the ASMBS and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). He has authored multiple publications and textbook chapters, including the recently published second edition of the ASMBS Textbook of Bariatric Surgery.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Guy-Bernard Cadi\u00e9re, MD, PhD<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Guy-Bernard Cadi\u00e8re, M.D., Ph.D. is Professor of Surgery at the Free University of Brussels. He is also Head of the Digestive Surgery Department at the Saint-Pierre University Hospital Center and is founding Director of the European School of Laparoscopic Surgery. He is also a visiting professor at several universities in Europe, the United States, South America, and Asia. Dr. Cadi\u00e9re has also worked for Doctors Without Borders and Doctors of the World.<\/p>\n

A pioneer in minimally invasive surgery techniques, he is at the origin of the creation of numerous surgical instruments and new operating techniques. In 1992, he performed obesity surgery by laparoscopy for the first time in the world. In 1999, he was the first surgeon in the world to perform laparoscopic surgery using a robot. In 2006, he performed the first transoral anti-reflux fundoplication.<\/p>\n

He has given more than 1000 lectures and carried out numerous operational demonstrations in universities all over the world. He is the author of more than 200 original publications in scientific journals and has also written surgical books and atlases.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>

\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Thomas M. Krummel, MD<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Thomas M. Krummel, M.D., is a Venture Partner at Sant\u00e9 Ventures. He joined Sant\u00e9 in 2021 from Stanford University, where he currently serves as Co-Director at the Byers Center for Biodesign and as the Emile Holman Professor Emeritus for the Department of Surgery in Stanford University\u2019s School of Medicine.<\/p>\n

For over 35 years, Dr. Krummel has served roles as surgeon, innovator, educator, and leader. In his position with the Stanford Byers Center for Biodesign for nearly 20 years, he has guided the teaching of medtech invention to teams of doctors, engineers, and business professionals through interdisciplinary research and education at the emerging frontiers of engineering and the biomedical sciences. More than 3.4 million patients have been treated with tools and technologies originating in this program. There are now 18 similar programs on three continents, with 227 graduates.<\/p>\n

Dr. Krummel is the recipient of the William E. Ladd Medal for 2020, the highest honor nationwide in pediatric surgery. He received one of the first Phased Innovation R21\/R33 grants from the National Institute of Health (NIH) to develop a simulation-based surgical training system. He has earned two ComputerWorld Smithsonian Awards for his work with surgical training systems and robotics and has co-authored more than 150 peer-reviewed articles.<\/p>\n

Dr. Krummel is Chair of the Board of Directors at Fogarty Innovation, a not-for-profit medtech educational incubator. He also serves on numerous boards of directors for Eclipse Regenesis, Morgridge Institute for Research at the University of Wisconsin-Madison, NewGen Surgical, and ULink. In addition, he served as President of the International Scientific Committee at IRCAD, University of Strasbourg, France. Dr. Krummel also serves as a consultant to the medical device industry and has served on boards of directors and scientific advisory boards of more than 20 successful early-stage medtech device start-ups.<\/p>\n

He received his M.D. from the Medical College of Wisconsin and his B.S. in chemistry from the University of Wisconsin-Parkside.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Jane Buchwald<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Jane Buchwald is Chief Scientific Research Writer and CEO\/Founder of the medical research writing and statistical analysis firm, Medwrite Medical Communications in Wisconsin.. She directs scientific writers and biostatisticians in development of original manuscripts from the data-analysis phase through publication in peer-reviewed articles. As a scientific research writer and editor, she has authored or contributed to more than 1,340 scientific documents, including more than 350 peer-reviewed articles and book chapters with a concentration in general and metabolic\/bariatric surgery. Her work has appeared in the\u00a0<\/span>Journal of the American Medical Association<\/em>,\u00a0<\/span>New England Journal of Medicine<\/em>,\u00a0<\/span>Journal of the American College of Surgeons<\/em>,\u00a0<\/span>Obesity Surgery<\/em>,\u00a0<\/span>Surgery for Obesity and Related Diseases<\/em>,\u00a0<\/span>Diabetes Care<\/em>, and the\u00a0<\/span>British Medical Journal<\/em>.<\/p>\n

In addition to academic collaborations, Ms. Buchwald has worked with more than 70 biomedical and pharmaceutical companies and scientific publishers to develop medical product and surgical procedure materials, books, and continuing medical education programs.<\/p>\n

Ms. Buchwald is author and director of the 25-chapter \u201clive\u201d and E-Learning postgraduate course\u201cWriting and Publishing a Research Article of Excellence (AOE),\u201d<\/em>\u00a0<\/span>a curriculum designed for physicians and healthcare professionals that details the development of peer-reviewed medical articles. The AOE course fills a training gap in scientific literature preparation that bridges clinical research and evidence-based practice. The course is presented in medical centers, global congresses, and U.S. military medical andsurgical residency programs.<\/p>\n

Ms. Buchwald also served as Editor-in-Chief of the\u00a0<\/span>Minnesota Physician<\/em>\u00a0<\/span>journal and as Technical Editor of\u00a0<\/span>The Report of the United States Surgeon General in 1994<\/em>\u00a0<\/span>(DHHS\/CDC). She received the American Medical Writers Association\u2019s Eric Martin Award for Excellence in Medical Writing, voted by the more than 5,000 peer membership committee. She is an active member and course director in the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO). Ms. Buchwald was educated at Macalester College, Cambridge University, and the State University of New York.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Henry Buchwald, MD, PhD<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Dr. Buchwald, M.D., Ph.D., F.A.C.S., Hon. F.R.C.S. (Eng) is Emeritus Professor of Surgery and Biomedical Engineering and the Owen H. and Sarah Davidson Wangensteen Chair in Experimental Surgery at the University of Minnesota. He attended Columbia College and the College of Physicians & Surgeons of Columbia University. As a surgeon-scientist, he has held numerous National Institutes of Health (NIH) grants and was the Principal Investigator of the 20-year NIH-funded Program on the Surgical Control of the Hyperlipidemias (the POSCH Trial), the first randomized clinical trial to demonstrate that cholesterol lowering by his partial ileal bypass operation resulted in reductions in cardiovascular disease and prolonged life expectancy. As a researcher, Dr. Buchwald is the author of over 360 peer-reviewed medical publications, more than 100 book chapters, books, and an atlas of surgery. He was also the primary author of the first meta-analysis of metabolic and bariatric surgery outcomes.<\/p>\n

During his career as a surgeon, patients have expressed their high regard for Dr. Buchwald\u2019s surgical skill, caring, and straightforward bedside manner. He maintains a lifetime commitment to his many trainees. Dr. Buchwald is one of the pioneers of bariatric surgery and is the co-author and primary advocate of the concept of metabolic surgery. He is the inventor and patent holder of 20 medical bioengineering devices, including the first implantable infusion pump for insulin therapy, heparin delivery, and continuous chemotherapy delivery, and he was the first surgeon to implant these novel devices. Dr. Buchwald was named Inventor of the Year in 1988 and inducted into the Minnesota Inventors Hall of Fame.<\/p>\n

Dr. Buchwald has served as Editor-in-Chief of the journal\u00a0<\/span>Obesity Surgery<\/em>\u00a0<\/span>and currently writes a bi-monthly column for\u00a0<\/span>General Surgery News<\/em>. He is past president of the International Federation for the Surgery of Obesity (IFSO), American Society for Metabolic\/Bariatric Surgery (ASMBS), Central Surgical Association, International Study Group for Implantable Insulin Delivery Devices (ISGIID), and the Owen H. Wangensteen Society. Dr. Buchwald is the recipient of numerous awards and honors in acknowledgment of his clinical and scholarly accomplishments, including the American College of Surgeons Jacobson Innovation Award (2019), in recognition of pioneering and innovative research in metabolic and bariatric surgery, and the Vagelos College of Physicians and Surgeons gold medal for achievement in research (2020). Among his election to several honorary societies, Dr. Buchwald was inducted into the Royal College of Surgeons of England. He lives with his wife, Emilie Buchwald, in Minneapolis.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>

\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Marielle Doyon<\/span><\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Marielle Doyon completed a chemical engineering degree from Universit\u00e9 Laval and completed her Ph.D. in pharmacology at Universit\u00e9 de Montr\u00e9al. Dr. Doyon is a registered patent agent and specializes in the drafting and prosecution of patent applications\u00a0in various technology fields. She also provides validity, infringement, freedom-to-operate and patentability opinions, particularly in the fields of medical devices, chemical engineering, and life sciences. Her academic research focuses on smooth muscle cell apoptosis induced by specific classes of antihypertensive drugs and on the implication of matrix Gla protein in the development of systolic hypertension in patients with type 1 diabetes.<\/span><\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Jeremy Lawson<\/span><\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Jeremy Lawson is a chemical engineer and a registered patent agent in both Canada and the United States. Mr. Lawson provides intellectual property counsel to business of all sizes in a wide range of technologies. He specializes in the drafting and prosecution of patent applications, patent portfolio management, due diligence, opinions on patent matters, and strategic counsel for pre-grant and post-grant patent challenges.<\/p>\n

Both Dr. Doyon and Mr. Lawson are partners with ROBIC, an internationally renowned firm founded in 1892 with a reputation for excellence intellectual property.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Kathryn Barry, MPH, MSN, RN<\/span><\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Kathryn Barry is Principal of Kathryn Barry & Associates (KBA), started in 2011. She is a healthcare marketing executive with niche background in hospital administration, nursing education, and medical devices. She has an impressive track record of success obtaining new codes, favorable medical policy decisions, and reimbursement rates.<\/p>\n

Previously, Ms. Barry was Vice President of Strategic Marketing at U.S. Surgical; Vice President of Marketing Communications at Tyco International; and Principal with Medical Education Training Associates, leading its Health Policy Practice for more than 10 years.<\/p>\n

Ms. Barry has a B.S. in nursing from the University of Pennsylvania, an M.S.in medical surgical nursing from Yale University School of Nursing, and a Master of Public Health (MPH) in policy and reimbursement from Yale University School of Medicine.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>

\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
<\/div>\"\"<\/span>\n\t\t\t<\/div>
<\/div><\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t

Yoshiki Kawabata<\/h2><\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
Bio<\/h5>\n\t\t\t\t

Business Development \u2013 GT Japan<\/strong><\/p>\n

As head of training for Autosuture Japanese Distributor during the launch of the first generation of mechanical staplers and endoscopic stapling, Yoshiki Kawabata oversaw the training of 3,000 Japanese surgeons. He continued his career in MIS surgery becoming head of Sales, then VP, for Ethicon End-Surgery. He then moved to St. Jude Medical and other multinational companies. Over the last few years, he helped U.S. start-up companies including HeatFlow, Inc., and Palette Lifesciences Inc., enter the Japanese market with great success.<\/p><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"dipi_cpt_category":[],"class_list":["post-1279","page","type-page","status-publish","hentry"],"yoast_head":"\nCompany - GT Metabolic Solutions<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Company - GT Metabolic Solutions\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/\" \/>\n<meta property=\"og:site_name\" content=\"GT Metabolic Solutions\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-10T15:48:54+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"24 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/company\\\/\",\"url\":\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/company\\\/\",\"name\":\"Company - GT Metabolic Solutions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/#website\"},\"datePublished\":\"2024-07-17T19:49:22+00:00\",\"dateModified\":\"2026-08-10T15:48:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/company\\\/#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/company\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/company\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/\",\"name\":\"GT Metabolic Solutions\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/gtmetabolic.webaloolabs.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Company - GT Metabolic Solutions","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/","og_locale":"en_US","og_type":"article","og_title":"Company - GT Metabolic Solutions","og_url":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/","og_site_name":"GT Metabolic Solutions","article_modified_time":"2026-08-10T15:48:54+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"24 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/","url":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/","name":"Company - GT Metabolic Solutions","isPartOf":{"@id":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/#website"},"datePublished":"2024-07-17T19:49:22+00:00","dateModified":"2026-08-10T15:48:54+00:00","breadcrumb":{"@id":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Company"}]},{"@type":"WebSite","@id":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/#website","url":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/","name":"GT Metabolic Solutions","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en"}]}},"_links":{"self":[{"href":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/wp-json\/wp\/v2\/pages\/1279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/wp-json\/wp\/v2\/comments?post=1279"}],"version-history":[{"count":16,"href":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/wp-json\/wp\/v2\/pages\/1279\/revisions"}],"predecessor-version":[{"id":2387,"href":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/wp-json\/wp\/v2\/pages\/1279\/revisions\/2387"}],"wp:attachment":[{"href":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/wp-json\/wp\/v2\/media?parent=1279"}],"wp:term":[{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/gtmetabolic.webaloolabs.com\/blog\/wp-json\/wp\/v2\/dipi_cpt_category?post=1279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}